These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2500670)

  • 1. Acute and chronic effects of oral enprostil, a synthetic dehydroprostaglandin E2, on uterine contractility.
    Pulkkinen MO
    Prostaglandins Leukot Essent Fatty Acids; 1989 Apr; 36(1):15-9. PubMed ID: 2500670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of postprandial glucose, insulin, C-peptide, and glucose-dependent insulinotropic peptide (GIP) in man by oral administration of a prostaglandin analogue (enprostil).
    Schwartz KE; Zaro B; Reynolds J; Duffy J; Saito T; Hunt JS; Sevelius H
    Horm Metab Res; 1988 Oct; 20(10):637-40. PubMed ID: 3146539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of serum lipoproteins in man by the oral administration of a prostaglandin analogue (enprostil).
    Schwartz KE; Zaro B; Burton P; Hunt J; Pennelly L; Sevelius H
    Atherosclerosis; 1988 May; 71(1):9-16. PubMed ID: 3132181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No abortion-inducing effect of the ulcer-healing dose of the synthetic prostaglandin E2 analogue enprostil in first trimester.
    Jacobson J; Bergquist C; Rydnert J; Bokström H; Huovinen K
    Acta Obstet Gynecol Scand; 1990; 69(2):135-8. PubMed ID: 2117332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of trimoprostil (trimethyldesoxy prostaglandin E2) on the intrauterine pressure in women.
    Reele SB; Nauss-Karol C; Lusaitis AA; Passe SM
    Clin Pharmacol Ther; 1988 Aug; 44(2):179-85. PubMed ID: 3293873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of duodenal ulcer with enprostil, a synthetic prostaglandin E2 analogue.
    Thomson AB
    Am J Med; 1986 Aug; 81(2A):59-63. PubMed ID: 3092657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synthetic prostaglandin E2 analogue, enprostil, hastens gastric emptying of solids in patients with an active duodenal ulcer.
    Nowak A; Jonderko K; Nowakowska-Duława E; Adamczak D; Rudzka J; Nowak S
    Scand J Gastroenterol; 1990 Nov; 25(11):1118-22. PubMed ID: 2125742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of PGE2 analogs interaction between food intake and antisecretory effect.
    Levine RA; Petokas S; Czarny L; Schwartz GJ; Bynum L
    Prostaglandins Leukot Med; 1986 Oct; 24(2-3):219-25. PubMed ID: 3099313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of enprostil on duodeno-jejunal motility in man.
    Ducrotte P; Parent B; Masliah C; Joubert M; Colin R; Denis P
    Aliment Pharmacol Ther; 1990 Feb; 4(1):73-81. PubMed ID: 2129489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of arbaprostil on the human non-pregnant uterus.
    Reele SB; Euler AR; Hanover CK; Lookabaugh JL
    Acta Obstet Gynecol Scand; 1985; 64(8):645-7. PubMed ID: 3914178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained enhancement of gastric HCO3 secretion in humans by enprostil.
    Guslandi M; Tittobello A
    Therapie; 1991; 46(1):13-5. PubMed ID: 1902327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of two-week treatment with enprostil (35 micrograms twice a day) on 24-hour serum gastrin levels.
    Florent C; Cogoni C; Joubert M; Desaint B
    Dig Dis Sci; 1990 Nov; 35(11):1352-7. PubMed ID: 2121423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of duodenal ulcer with enprostil, a prostaglandin E2 analogue.
    Bright-Asare P
    Am J Med; 1986 Aug; 81(2A):64-8. PubMed ID: 3092658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enprostil, in contrast to cimetidine, does not inhibit propranolol metabolism.
    Reilly CS; Biollaz J; Koshakji RP; Wood AJ
    Clin Pharmacol Ther; 1986 Jul; 40(1):37-41. PubMed ID: 3087677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.
    Thomas FJ; Koss MA; Hogan DL; Isenberg JI
    Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of enprostil on plasma glucose, insulin and lipid metabolism in patients with non-insulin-dependent diabetes mellitus.
    Reaven GM; Swislocki AL; Jeng CY; Hollenbeck CB; Schwartz K; Chen YD
    Horm Metab Res; 1988 Oct; 20(10):633-6. PubMed ID: 3146538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of enprostil on gastric emptying, intestinal transit time and post-prandial release of gastro-intestinal peptides.
    Nicholl CG; Carolan G; Sevelius H; Bloom SR
    Digestion; 1989; 43(1-2):47-55. PubMed ID: 2509267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enprostil and ranitidine in duodenal ulcer healing: double blind comparative trial.
    Lauritsen K; Laursen LS; Havelund T; Bytzer P; Svendsen LB; Rask-Madsen J
    Br Med J (Clin Res Ed); 1986 Mar; 292(6524):864-6. PubMed ID: 3083913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of alimentary lipemia in man by a prostaglandin analogue (enprostil).
    Schwartz KE; Saito T
    Atherosclerosis; 1989 Oct; 79(2-3):231-6. PubMed ID: 2512938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A US multicenter study of enprostil 35 micrograms twice daily for treatment of prepyloric, pyloric channel, and duodenal bulb ulcers. Enprostil Study Group.
    Schubert TT; Frizzell JA; Meier PB; Cano RI; Schwartz KE
    Dig Dis Sci; 1989 Sep; 34(9):1355-60. PubMed ID: 2504566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.